Mednet Logo
SpecialtiesPulmonology
Pulmonology

Pulmonology

Physician discussions on respiratory conditions, critical care, interstitial lung disease, and pulmonary procedures.

Recent Discussions

What criteria do you use to decide when to perform a BAL in hypersensitivity pneumonitis?

2 Answers

Mednet Member
Mednet Member
Pulmonology · University of North Carolina @ Chapel Hill

Short answer: When the vibes are right. I know that's a flippant answer, but that's an honest-to-God real answer. Long answer: This is really complicated and personally, I'm frustrated by our guidelines and the level of evidence we have for diagnosing HP. To answer the question, it's worth delineati...

Do you transcutaneously pace or cardiovert patients with DNR status who have not lost pulses?

2
4 Answers

Mednet Member
Mednet Member
Pulmonology · Emory University Hospital Midtown

Yes, since it would not qualify as cardiopulmonary resuscitation if they maintain a pulse.

In patients treated with infliximab, do rates of immunogenicity vary based on underlying disease (RA, IBD, sarcoidosis, etc) and/or baseline disease activity?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

Yes, rates of infliximab immunogenicity appear to vary based on underlying disease, with evidence showing higher rates for RA than IBD and spondyloarthritis, and tend to increase with higher baseline disease activity. Most patients tend to develop anti-drug antibodies within the first year, but this...

How have you incorporated prescription digital therapeutic treatments for chronic insomnia, such as SleepioRx or Somryst, into your practice?

1
3 Answers

Mednet Member
Mednet Member
Psychiatry · UCI School of Medicine

I have not yet prescribed any of the digital therapeutic treatments, but there are key differences. The US Department of Veteran Affairs developed CBT-i Coach based on the therapy manual CBT for Insomnia in Veterans, and the app is free to use. CBT-i Coach is intended to augment face-to-face care wi...

Do you routinely give combination antifungal therapy for invasive mold infections?

1 Answers

Mednet Member
Mednet Member
Infectious Disease · Perelman School of Medicine at the University of Pennsylvania

The data on triazole single agent versus triazole plus echinocandin for the treatment of invasive aspergillosis are limited. I do not have a standard approach. I generally use a triazole alone, but will use the combination for initial treatment in patients with severe and/or rapidly progressive dise...

Do you use MRSA nares PCR to influence antibiotic selection for non-respiratory infections?

3
2 Answers

Mednet Member
Mednet Member
Hospital Medicine · UT Health

BLUF: Yes, I use a MRSA nares PCR for early de-escalation in the stable patient with a non-purulent, non-respiratory infection. Mergenhagen et al., PMID 31573026 retrospectively examined nearly half a million clinical cultures and compared them to MRSA nares results. Among all infections, the NPVs w...

When have you found hypnosis helpful for parasomnia?

1 Answers

Mednet Member
Mednet Member
Neurology · Northwestern University

Usually, when treating NREM parasomnias such as sleep terrors and sleepwalking, the patient has to practice the techniques every night in addition to removing identified triggers.

How often do you have worsening hypoxia with patients started on sotatercept?

1 Answers

Mednet Member
Mednet Member
Pulmonology · Augusta University Medical College Of Georgia

I have not observed hypoxia with sotatercept. I have seen in a proportion of patients on IV Remodulin as they are titrated in the ICU, usually those with borderline wedge pressures and diastolic dysfunction.

Among patients with secured subarachnoid hemorrhage who are receiving daily TCDs, what is the appropriate frequency of post operative neurological assessments?

2 Answers

Mednet Member
Mednet Member
Neurology · University of Pennsylvania

I think a textbook might state something like "every 1-2 hours in the acute setting." However, in my opinion, the frequency of neurological examinations should be tailored to the individual patient and involves considerable clinical judgement. Factors that might influence this decision include a) se...

When pulmonary vasodilator therapy lowers PVR to transplant targets but causes systemic hypotension or worsening renal perfusion in decompensated cirrhosis, how do you adjust therapy (dose reduction, agent change, accepting higher PVR) while preserving both hemodynamic eligibility and overall transplant candidacy?

2 Answers

Mednet Member
Mednet Member
Pulmonology · Mayo Clinic Pulmonary Medicine

Fortunately, an uncommon problem, but when it does occur, careful dose reduction of the offending agent may help. Also, I would consider going from any offending oral medication to an inhaled prostacyclin to avoid/minimize systemic effects.